Clinical trial Recruiting at 1 site Observational Ages 45 to 75

Assessing endurance in Parkinson's patients using a pegboard test

Official title: Investigation of the Validity and Reliability of the 6-Minute Pegboard and Ring Test in Parkinson's Patients for Upper Extremity Endurance Assessments

Run by Karadeniz Technical University · NCT06482502 · Data updated 2026-11-12

This study is testing a new pegboard test to see if it can effectively measure upper body endurance in people with Parkinson's disease.

Quick facts

Study typeObservational
Ages45 Years to 75 Years
SexAll
Enrollment34 (estimated)
SponsorKaradeniz Technical University
Academic / other
Locations1 site (Istanbul)
StatusRecruiting
StartedMay 20, 2024
Main results expectedAugust 31, 2024
Study endsDecember 31, 2025
Registry record updatedMarch 7, 2025
Trial IDNCT06482502 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals with Parkinson's disease who have a Hoehn & Yahr staging of 3 or less and meet specific upper extremity mobility criteria.

Probably not a fit

Patients with severe heart disease, orthopedic problems affecting the upper extremity, or secondary neurological diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the validity of the 6-Minute Pegboard and Ring Test (6-MPRT) as a measure of upper extremity endurance in patients with Parkinson's disease. The study will involve two assessments conducted on the same day by different evaluators, with a follow-up assessment occurring two days later. In addition to the 6-MPRT, other tests such as the Weight Lifting Test and the 30-Second Arm Curl Test will also be utilized to evaluate endurance. The goal is to determine if the 6-MPRT can be effectively used in this patient population, where current assessment methods are limited.

Why it matters

Potential benefit: If successful, this study could provide a reliable method for assessing upper extremity endurance in Parkinson's patients, potentially improving rehabilitation strategies.

How similar studies have gone: Previous studies have validated the 6-MPRT in other respiratory disease groups, suggesting potential applicability in Parkinson's patients, though this specific application is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Hoehn \& Yahr staging ≤3 points,
* Individuals who have not undergone a rehabilitation program of at least 20 days in the last 6 months,
* Those with full upper extremity shoulder flexion and abduction active joint range of motion.

Exclusion Criteria:

* Those with severe heart disease such as heart failure, cardiac arrhythmia, hypertension,
* People with any orthopedic problem that will affect the upper extremity,
* Having a secondary neurological disease diagnosis,
* Having vision impairment that may affect measurement methods (not corrected by glasses),
* Having a cognitive disease that may cause difficulty in following the researchers\' commands,
* Those who had changes in their medical use during the test (dose increase/decrease, drug change

Where it's running

  • İstanbul Medilife Beylikdüzü Hospital
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.